Fahrleitner-Pammer, Astrid <br/><br/>
Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Jul 2009 
 - 1335-44 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1359/jbmr.090216  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acid Phosphatase--blood<br/>Adult<br/>Antacids--administration & dosage<br/>Biomarkers--blood<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Resorption--blood<br/>Calcium Carbonate--administration & dosage<br/>Cholecalciferol--administration & dosage<br/>Collagen Type I--blood<br/>Diphosphonates--administration & dosage<br/>Double-Blind Method<br/>Heart Transplantation<br/>Humans<br/>Ibandronic Acid<br/>Isoenzymes--blood<br/>Lumbar Vertebrae--injuries<br/>Male<br/>Middle Aged<br/>Radiography<br/>Spinal Fractures--blood<br/>Tartrate-Resistant Acid Phosphatase<br/>Time Factors<br/>Transplantation, Homologous